Evaluation of the Autonomic Nervous System in Patients Undergoing Esophagectomy for Cancer
NCT04835987 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-11-24
Summary
Esophageal surgery is a complex surgery, with high post-operative morbidity and mortality. The incidence of complications associated with esophagectomy varies from 17% to 74%, in the literature. A section of vagus nerves is conventionally performed during esophagectomy for cancer, because of oncological margins. The vagus nerve is responsible for the parasympathetic innervation at the gastrointestinal level, but also at the cardiac and pulmonary level. The post-operative morbidity of these procedures could be linked in part to the bilateral section of the vagus nerves, because of their impact on the autonomous regulation of this vital functions. The main objective of the study is to find a modification of the sympathomimetic balance pre and post operatively, in patients undergoing esophagectomy.
Conditions
- Esophageal Cancer
Interventions
- DIAGNOSTIC_TEST
-
Holter ECG
Measurement of the modification of the sympathomimetic balance
- BEHAVIORAL
-
Questionary
Lifestyle questionary (time spent in front of television, physical activity)
- DIAGNOSTIC_TEST
-
Pupillometry
Monitoring of nociception and autonomic nervous system by pupillometry in intraoperative.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Saint Etienne
lead OTHER
Principal Investigators
-
EVE HUART, MD · CHU ST ETIENNE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-31
- Primary Completion
- 2024-03-31
- Completion
- 2024-09-30
Countries
- France
Study Locations
More Related Trials
-
Non-intubated Versus Intubated Anesthesia in Thoracoscopic Esophagectomy for Esophageal Cancer
NCT07104838 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy
NCT05420480 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Esophagectomy With or Without Prior Ischemic Gastric Preconditioning
NCT02457299 ·Status: TERMINATED ·Phase: NA
-
Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
NCT01349517 ·Status: UNKNOWN ·Phase: PHASE2
-
Textbook Outcomes After Oesophagectomy in Regional Australia
NCT06721715 ·Status: NOT_YET_RECRUITING
-
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
NCT00544362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction
NCT02287129 ·Status: COMPLETED ·Phase: PHASE2
-
Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study
NCT04440124 ·Status: COMPLETED
-
A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
NCT00760604 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy
NCT02551458 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
NCT00047112 ·Status: COMPLETED ·Phase: PHASE3
-
Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach
NCT02448979 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
NCT06833775 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma
NCT00733889 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
NCT00735345 ·Status: TERMINATED ·Phase: PHASE2
-
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
NCT06385717 ·Status: RECRUITING
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer
NCT04443478 ·Status: RECRUITING
-
Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION)
NCT05996276 ·Status: UNKNOWN
-
A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION
NCT03151642 ·Status: COMPLETED
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA
-
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
NCT00757172 ·Status: COMPLETED ·Phase: PHASE2
-
Open Versus Laparoscopically-assisted Esophagectomy for Cancer
NCT00937456 ·Status: COMPLETED ·Phase: NA
-
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
NCT00109850 ·Status: TERMINATED ·Phase: PHASE2
-
Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)
NCT01807936 ·Status: COMPLETED ·Phase: NA